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ABSTRACT The physiological roles of phospholipase C
(PLC) b2 in hematopoiesis, leukocyte function, and host
defense against infection were investigated using a mouse line
that lacks PLC b2. PLC b2 deficiency did not affect hema-
topoiesis, but it blocked chemoattractant-induced Ca21 re-
lease, superoxide production, and MAC-1 up-regulation in
neutrophils. In view of these effects, it was surprising that the
absence of PLC b2 enhanced chemotaxis of different leuko-
cyte populations and sensitized the in vivo response of the PLC
b2-deficient mice to bacteria, viruses, and immune complexes.
These data raise questions about the roles that PLC b2 may
play in signal transduction induced by chemoattractants in
leukocytes.
Phospholipase C (PLC) hydrolyzes phosphatidylinositol 4,5-
bisphosphate to produce two important second messengers,
inositol trisphosphates and diacylglycerol (1). There are four
different PLC b isoforms that have been cloned. They are all
regulated by heterotrimeric G proteins, and there is evidence
suggesting that different isoforms may be involved in a variety
of signaling circuits. The b2 isoform is found primarily in
hematopoietic cells (2, 3), and it can be activated by both the
Ga subunits of the Gq class and by the bg subunits generated
by a number of different heterotrimeric G proteins (3–9).
Cotransfection experiments in COS-7 and HEK cells suggest
that PLC b2 may function downstream of chemoattractant
receptors. Transfection of receptors for complement compo-
nent C5a and fMet-Leu-Phe (fMLP) (10), interleukin (IL)-8
receptors a and b (11), and CKR-1 and -2 (12) demonstrated
that each of the receptors activates PLC b2 through the
pertussis toxin (PTx)-sensitive release of bg from the Gi class
of heterotrimeric G proteins. In addition, this may be a primary
signaling pathway in neutrophils, because much of the PLC
activity elicited through chemoattractant receptors also ap-
pears to function through the Gi-mediated release of bg
(13–17).
To confirm the existence of the Gbg–PLC b2 pathway in
vivo and to investigate the function of the pathway in hema-
topoiesis and leukocyte function, we generated a mouse line
that lacks PLC b2. We found that PLC b2 is the major isoform
that mediates PTx-sensitive PLC activation induced by che-
moattractants and that PLC b2 is critical to many chemoat-
tractant-elicited responses, including Ca21 efflux, superoxide
production, and up-regulation of MAC-1. However, PLC b2
deficiency does not attenuate chemoattractant-induced che-
motaxis; surprisingly, it was found to enhance the process.
MATERIALS AND METHODS
Generation of PLC b2-Null Mice. An 8-kb genomic DNA
from a 129SV agouti mouse strain library contains two exons
of the PLC b2 gene, and it was used to make the gene-targeting
construct. The exons encoded residues 378–464, which are
located in the C terminus of the X box. Parts of the exons were
replaced with a neomycin-resistance gene. The gene-targeting
construct was transfected into embryonic stem (ES) cells (CJ7
clone) by electroporation. After selection with Geneticin, eight
ES clones were obtained in which one of the PLC b2 genes was
disrupted. Two of the ES cell clones were microinjected into
blastocysts, and eight chimeras were generated with chimerism
ranging from 40% to 95%. These chimeras were then back-
crossed with 129SV to generate inbred heterozygotes. Finally,
interbreeding of heterozygous siblings yielded animals ho-
mozygous for the desired mutation—i.e., mice lacking PLC b2.
The animals are maintained under specific pathogen-free
conditions.
PLC Assays. Neutrophils used for PLC assays were isolated
from mouse bone marrow by using a neutrophil isolation kit
from Cardinal Associates (Santa Fe, NM). Cells were labeled
overnight with [3H]inositol at 5 mCiyml (1 mCi 5 37 kBq), and
the levels of inositol phosphates were determined as previously
described (18).
Ca21 Efflux, Superoxide Production, and Surface MAC-1
Expression Assays. Mice (8–10 weeks old) were injected
intraperitoneally with 2 ml of 2% casein (19). After 3 hr the
peritoneal cavities were lavaged with Hanks’ balanced salt
solution (HBSS), and the peritoneal exudate cells (PEC) were
collected by low-speed centrifugation. The percentage of
neutrophils was determined by cytospin differential count;
typically the recovered cells were .90% neutrophils. The cells
were spun down and resuspended in HBSS and were ready for
the assays. In the Ca21 assays, PEC were loaded with Fura-
2yAM (1 mM) in HBSS at 37°C for 30 min and washed twice
with HBSS. The cells were resuspended in HBSS, and the
340y380-nm excitation ratio (emission 5 510 nm) of the cells
in the absence and presence of ligand was determined with a
fluorometer as directed by the user manual (Quantamaster,
Photon Technology International, Princeton, NJ). The intra-
cellular [Ca21] was calculated on the basis of a calibration scale
generated by using Fura-2 free acid (20).
The levels of superoxide anion in neutrophils were deter-
mined as previously described (21). Briefly, PEC were primed
with or without 0.2 mgyml lipopolysaccharide (LPS) at 37°C for
15 min. A cocktail of p-hydroxyphenylacetate (10 mgyml),
superoxide dismutase (1 mgyml), and horseradish peroxidase
(8 mgyml) was made up in a volume ratio of 25:40:10, and 20
ml was used per 100 ml of cell suspension. Cells were incubated
with the cocktail in either the absence or the presence of
chemoattractant fMLP (1 mM) at 37°C for 60 min. The cells
were excited at 323 nm, and the emission at 400 nm was
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measured. The superoxide anion concentrations were calcu-
lated on the basis of a standard curve generated with known
concentrations of hydrogen peroxide.
Surface expression of MAC-1 on neutrophils was assessed by
incubating cells with 1 mM fMLP for 5 min at 37°C and then
incubating with fluorescein isothiocyanate-conjugated rat an-
ti-MAC-1 antibody or rat isotype-matched control antibody on
ice for 30 min. MAC-1-positive cells were identified in a gated
population based on forward and side scatter profiles. Flow
cytometry was performed using an Elite Flowcytometer
(Coulter). Data were acquired with 10,000 cells per sample and
expressed as the percentage of maximal mean channel f luo-
rescence minus that obtained with the control antibody.
Chemotaxis Assay. Bone marrow cells were freed of red
blood cells by hypotonic lysis, and the CD31 T cells were
isolated from spleen by negative selection using the mouse T
cell enrichment kit from R & D Systems. The cells were
resuspended at a concentration of 107 cells per ml in HBSS,
and chemotaxis in response to various ligands was determined
by loading individual chambers of a 48-well chemotaxis appa-
ratus (Nuclepore) with 50 ml of cells. The chamber was
incubated at 37°C for 1 hr. Migrating cells adhering to the
bottom of the membrane separating the chambers were stained
with Diff-Quick (Fisher) and counted under 4003 magnifica-
tion. The cells in five random fields were counted, noting the
differential percentages of mononuclear cells, neutrophils, and
eosinophils.
RESULTS
The PLC b2 gene was disrupted as shown in Fig. 1A. The X and
Y boxes represent conserved amino acid sequence motifs
found in all members of the PLC family, and they comprise the
catalytic domain responsible for PLC activity (22). The exon of
the PLC b2 gene, which encodes part of the X box, was
disrupted by the insertion of a neomycin-resistance gene-
expression unit. Homologous recombinants that maintained
the null mutation in the PLC b2 gene were detected by PCR
with the primers shown in Fig. 1 A, and the genomic structure
was confirmed by Southern analysis (data not shown). No PLC
b2 protein was detected with a PLC b2-specific antiserum in
homogenates from homozygous PLC b2-deficient mice (Fig.
1B).
The homozygous deficient mice show no apparent pheno-
types at the systemic and cellular levels; PLC b2-deficient mice
are similar to wild-type littermates in body weight, survival
rate, appearance, and behavior. Flow cytometric analyses did
not reveal any significant changes in populations of CD31,
CD41, CD81, IgM1, CD451, Gr-1, MAC-11, and Mac-31 cells
derived from spleen, thymus, and bone marrow. Differential
leukocyte counts of cells with morphologies corresponding to
mononuclear cells, eosinophils, and neutrophils in bone mar-
row, peripheral blood, and peritoneal cavity lavage were
similar in PLC b2-deficient and wild-type mice. Therefore,
PLC b2 does not appear to be required for production of
leukocytes.
To understand the involvement of PLC b2 in chemoattrac-
tant-induced responses, we investigated how the deficiency
affects inositol phosphate accumulation, superoxide produc-
tion, elevation of intracellular Ca21, and chemotaxis in re-
sponse to chemoattractants. The fMLP-induced accumulation
of inositol phosphates in neutrophils isolated from the bone
marrow of PLC b2-null and wild-type mice was determined. As
shown in Table 1, fMLP induced significant increases in the
levels of inositol phosphates in neutrophils from wild-type
mice, and the response was sensitive to PTx. However, fMLP-
induced accumulation of inositol phosphates was significantly
reduced in neutrophils isolated from the PLC b2-null mice,
although the levels of inositol phosphates remained at 20% of
1y1 levels. Given the absence of PLC b2 protein (Fig. 1B), the
residual activity is likely the result of other PLC b isoforms
andyor PLC g isoforms that are regulated by fMLP. In any
event, it is clear that PLC b2 is the major isoform that mediates
the PTx-sensitive accumulation of inositol phosphates induced
by fMLP.
fMLP-mediated Ca21 release, superoxide production, and
up-regulation of MAC-1 expression in neutrophils were also
investigated. In neutrophils lacking PLC b2, there was only
about a 30% increase in fMLP-induced intracellular Ca21
compared with neutrophils derived from wild-type mice (Ta-
ble 1). Similar results were also observed with IL-8- and
MIP-1a-induced activation (data not shown). We also found
that fMLP (Table 1), IL-8, and MIP-1a (data not shown)-
induced superoxide production and up-regulation of cell sur-
face expression of MAC-1 were significantly attenuated in
neutrophils lacking PLC b2 (Table 1). In contrast, lipopolysac-
charide-induced superoxide production was not affected in
neutrophils lacking PLC b2 (data not shown). Thus, the
mechanism for the induced response is intact, but coupling to
the chemoattractant receptors is lost in these cells. We con-
clude that PLC b2 plays a central role in specific chemoat-
tractant-induced superoxide production and up-regulation of
MAC-1 as well as in chemoattractant-induced Ca21 release
and inositol trisphosphate formation in neutrophils.
One of the major biological responses mediated by che-
moattractants is chemotaxis of leukocytes along a gradient of
attractant (23). fMLP- and IL-8-induced chemotaxis activities
were assessed using leukocytes isolated from bone marrow of
PLC b2-null and wild-type mice in Boyden chamber assays.
Both ligands attracted only neutrophils as judged on the basis
of the morphology of the migrating cells bound to the mem-
brane after differential staining. It is clear that IL-8- and
fMLP-induced chemotaxis of PLC b2-deficient neutrophils
was not impaired (Fig. 2 A and B). On the contrary, neutrophils
derived from the PLC b2-null mice were consistently found to
be slightly more sensitive to lower concentrations of fMLP and
IL-8 in the chemotaxis assays (Fig. 2 A and B). MIP-1a-
induced chemotaxis of bone marrow leukocytes was also
investigated. MIP-1a attracted both mouse polymorphonu-
FIG. 1. Generation of PLC b2-null mice. (A) Gene-targeting
construct and the homologous recombination process. R1, EcoRI
restriction site. (B) Western analysis of mouse tissues with a PLC-b2-
specific antibody. Spleen and thymus homogenates from the wild type
(1y1), heterozygous (1y2), and homozygous (2y2) mice were
separated on a 7.5% polyacrylamide gel, transferred to a nitrocellulose
membrane, and detected with a PLC b4-specific antibody (Santa Cruz
Biotechnology). MW is a molecular weight standard of 200,000.
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clear and mononuclear cells. Once again, cells lacking PLC b2
were more effectively recruited by MIP-1a-induced chemo-
taxis than those containing PLC b2 (Fig. 2C). In particular,
MIP-1a-induced chemotaxis of mouse eosinophils was greatly
enhanced in the absence of PLC b2 (Fig. 2C). The mononu-
clear cells attracted by MIP-1a included both monocytes and
lymphocytes. To investigate the chemotaxis of lymphocytes,
we isolated CD31 T cells from spleen. We tested both MIP-1a
and RANTES as chemoattractants that are known for their
ability to induce activity in T lymphocytes (13–15). Both
ligands induced stronger chemotaxis activity in cells lacking
PLC b2 (Fig. 2 D and E). The study was also extended to
eotaxin-induced chemotaxis of eosinophils. Eotaxin, like the
other chemoattractants, elicited stronger chemotaxis activity
from eosinophils that lacked PLC b2 than from wild-type cells
(Fig. 2F). In summary, deficiency in the PLC b2-linked
pathway does not decrease the chemotaxis response as mea-
sured by the Boyden chamber assay; instead the loss of the PLC
b2 pathway augments chemotaxis. The observations of en-
hanced chemotaxis were confirmed using an in vivo model of
leukocyte recruitment. Mice were sensitized with two subcu-
taneous injections of methylated bovine serum albumin
(MBSA) or saline solution over a 2-week period, followed 1
week later by an intrathoracic injection of MBSA. The day
following this challenge the thoracic cavity was flushed with
sterile saline containing heparin. The total number of nucle-
ated cells and the fraction of eosinophils in the thoracic cavity
of the MBSA-immunized mutant and wild-type mice were
compared. Approximately 4 times as many eosinophils (5.4 6
1.2 3 105) were recruited in the PLC b2-null mice (n 5 7) as
in the wild-type animals (1.5 6 0.4 3 105, n 5 5). These data
are consistent with the in vitro results and demonstrate that
eosinophils derived from PLC b2-null mice have enhanced
chemotactic responses.
The potential systemic effects of the PLC b2 deficiency were
assessed by using two models of infection. Bacterial infection
was achieved by injecting mice with ampicillin-resistant bac-
teria. The resulting peritonitis was assessed the following day
as a function of the number of surviving bacteria recovered
from a peritoneal cavity lavage. The number of bacteria that
FIG. 2. Chemoattractant-elicited chemotaxis. Bone marrow cells (A, B, C, and F) and CD31 T cells (D and E) were loaded into individual
chambers of a 48-well chemotaxis apparatus. The chamber was incubated at 37°C for 1 hr. Migrating cells adhering to the bottom sides of the
membrane separating the chambers were stained with Diff-Quick (Fisher) and counted. The cells in five random fields were counted, noting the
differential percentages of mononuclear cells (MN; open symbols), neutrophils (PMN; filled symbols), and eosinophils (EO; crossed symbols). Cells
isolated from PLC b2-null mice and from the wild-type mice are represented by squares and circles, respectively. The data are presented as mean 6
SEM.
Table 1. fMLP-elicited responses in murine neutrophils
Mice
Inositol phosphates,
dpm* Ca21, nM† Superoxide,
pmolymin MAC-1, %‡2 PTx 1 PTx 2 PTx 1 PTx
PLC b2 1y1 1,247 6 94 137 6 50 101 6 15 ND 13.8 6 2.1 100
PLC b2 2y2 239 6 89 120 6 75 29 6 4 ND 1.66 6 0.5 25.2 6 10.2
Data are shown as mean 6 SEM. At least three independent experiments were performed. ND, not
detected.
*The basal level of inositol phosphates is 898 6 110 dpm.
†The resting Ca21 concentration is 84.2 6 8.9 nM.
‡Data are expressed as a percentage of the 1y1 levels.
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survived in PLC b2-null mice was less than in the wild-type
mice (Fig. 3A). This result suggests that the PLC b2 deficiency
does not compromise the host’s ability to deal with the
bacterial challenge. The mice were also challenged with Friend
leukemia virus (FLV), which induces splenomegaly (24). FLV
was injected peritoneally, and 2 weeks later the spleens were
weighed. The weights of wild-type spleens infected with FLV
were double those of noninfected, but FLV induced only slight
increases in spleen weight in the PLC b2-null mice (Fig. 3B).
There is a clear statistical difference between the weight of the
PLC b2-null spleens and those of wild type after treatment
with FLV. This difference together with the difference in the
bacterial survival rate suggests that disruption of the PLC
b2-linked pathway does not impair, and may even enhance, the
in vivo response to bacterial and viral exposure.
DISCUSSION
Our data delineate two apparently different functions for PLC
b2 in responses mediated by chemoattractant receptors. PLC
b2 deficiency results in a significant reduction of chemoat-
tractant-induced inositol phosphate accumulation, intracellu-
lar Ca21 levels, superoxide production, and cell surface
MAC-1 expression. However, leukocytes lacking PLC b2
showed enhanced chemoattractant-induced chemotaxis.
These results suggest that specific immediate molecular re-
sponses to chemoattractants are mediated through PLC b2
signaling, but more complex responses such as chemotaxis are
regulated by inputs from a number of pathways. Our data
suggest that PLC b2 may be part of a negative pathway that
attenuates chemotaxis. Previous reports (25–29) have impli-
cated protein kinase C (PKC) in desensitization of G protein-
mediated signal transduction, including responses to fMLP,
IL-8, and platelet-activating factor. PLC b2 may be a required
component of this desensitization pathway. In addition, the
role of PLC b2 is cell-specific, since PLC b2-null leukocyte
populations differentially responded to chemoattractants (Fig.
2). Our results also suggest that PLC b2-mediated superoxide
production and up-regulation of MAC-1 in neutrophils may
not be essential for the host’s response to bacterial challenges.
We do not know if the enhanced chemotaxis observed in the
leukocytes is the cause of the apparent increase in resistance
to viral challenge. Nevertheless, it is clear that PLC b2 plays
a role in leukocyte functions at the cellular and at the whole
animal level. The PLC b2 mice provide a means to analyze the
contributions of various signal transduction pathways to com-
plex cellular and tissue functions in vivo.
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